Rapamycin, but not cyclosporine A, inhibits vascularization and incorporation of implanted surgical meshes

Transplant International

Volumn 22, Issue 6, 2009, Pages 654-662

  Laschke, Matthias W ^a   Häufel, Jörg M ^a   Roller, Jonas ^a   Schorr, Heike ^a   Menger, Michael D ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Cyclosporine; Hernia repair; Immunosuppression; Rapamycin; Surgical mesh

Indexed keywords

CYCLOSPORIN A; RAPAMYCIN; ULTRAPRO MESH; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; GRANULATION TISSUE; HERNIOPLASTY; HISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INCISIONAL HERNIA; LEUKOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; SKINFOLD; SURGICAL EQUIPMENT; SYRIAN HAMSTER;

ANIMALS; CELL ADHESION; CRICETINAE; CYCLOSPORINE; ENDOTHELIAL CELLS; HERNIA, ABDOMINAL; HERNIA, VENTRAL; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES; MALE; MESOCRICETUS; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; SIROLIMUS; SURGICAL MESH;

EID: 65549104360     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00841.x     Document Type: Article

References (37)

1. Kahn J, Müller H, Iberer F, et al. Incisional hernia following liver transplantation: incidence and predisposing factors. Clin Transplant 2007 21 : 423. (Pubitemid 46711409)
2. Toso C, Meeberg GA, Bigam DL, et al. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation 2007 83 : 1162. (Pubitemid 46743675)
3. Piazzese E, Montalti R, Beltempo P, et al. Incidence, predisposing factors, and results of surgical treatment of incisional hernia after orthotopic liver transplantation. Transplant Proc 2004 36 : 3097. (Pubitemid 41126750)
4. Kelley SF, Felix AM, Ehrlich HP. The antagonism of glucocorticoid inhibition of wound healing in rats by growth hormone-releasing factor. Proc Soc Exp Biol Med 1990 194 : 320. (Pubitemid 20284202)
5. Guilbeau JM. Delayed wound healing with sirolimus after liver transplant. Ann Pharmacother 2002 36 : 1391.
6. Schäffer M, Schier R, Napirei M, Michalski S, Traska T, Viebahn R. Sirolimus impairs wound healing. Langenbecks Arch Surg 2007 392 : 297. (Pubitemid 46675809)
7. Mekeel K, Mulligan D, Reddy KS, Moss A, Harold K. Laparoscopic incisional hernia repair after liver transplantation. Liver Transpl 2007 13 : 1576. (Pubitemid 350168200)
8. Luijendijk RW, Hop WC, van den Tol MP, et al. A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 2000 343 : 392. (Pubitemid 30626121)
9. Zanghì A, Di Vita M, Lomenzo E, De Luca A, Cappellani A. Laparoscopic repair vs open surgery for incisional hernias: a comparison study. Ann Ital Chir 2000 71 : 663.
10. Laschke MW, Häufel JM, Thorlacius H, Menger MD. New experimental approach to study host tissue response to surgical mesh materials in vivo. J Biomed Mater Res A 2005 74 : 696. (Pubitemid 41216271)
11. Roller J, Laschke MW, Sethi S, Herrmann M, Menger MD. Prolene-Monocryl-composite meshes do not increase microvascular Staphylococcus aureus adherence and do not sensitize for leukocytic inflammation. Langenbecks Arch Surg 2008 393 : 349.
12. Endrich B, Asaishi K, Götz A, Messmer K. Technical report - a new chamber technique for microvascular studies in unanesthetized hamsters. Res Exp Med (Berl) 1980 177 : 125. (Pubitemid 11238699)
13. Menger MD, Laschke MW, Vollmar B. Viewing the microcirculation through the window: some twenty years experience with the hamster dorsal skinfold chamber. Eur Surg Res 2002 34 : 83. (Pubitemid 34195702)
14. Laschke MW, Witt K, Pohlemann T, Menger MD. Injectable nanocrystalline hydroxyapatite paste for bone substitution: in vivo analysis of biocompatibility and vascularization. J Biomed Mater Res B Appl Biomater 2007 82 : 494.
15. Menger MD, Pelikan S, Steiner D, Messmer K. Microvascular ischemia-reperfusion injury in striated muscle: significance of "reflow paradox". Am J Physiol 1992 263 : H1901. (Pubitemid 23030745)
16. Rücker M, Laschke MW, Junker D, et al. Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice. Biomaterials 2006 27 : 5027. (Pubitemid 43949420)
17. Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002 8 : 128. (Pubitemid 34155123)
18. Vajkoczy P, Vollmar B, Wolf B, Menger MD. Effects of cyclosporine A on the process of vascularization of freely transplanted islets of Langerhans. J Mol Med 1999 77 : 111. (Pubitemid 29146196)
19. Laschke MW, Elitzsch A, Scheuer C, Holstein JH, Vollmar B, Menger MD. Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation. Br J Pharmacol 2006 149 : 137. (Pubitemid 44360094)
20. Holstein JH, Klein M, Garcia P, et al. Rapamycin affects early fracture healing in mice. Br J Pharmacol 2008 154 : 1055.
21. Stepkowski SM. Preclinical results of sirolimus treatment in transplant models. Transplant Proc 2003 35 : 219S. (Pubitemid 36547947)
22. Menger MD, Walter P, Hammersen F, Messmer K. Quantitative analysis of neovascularization of different PTFE-implants. Eur J Cardiothorac Surg 1990 4 : 191.
23. Paghdal KV, Schwartz RA. Sirolimus (rapamycin): from the soil of Easter Island to a bright future. J Am Acad Dermatol 2007 57 : 1046. (Pubitemid 350087332)
24. Quesniaux VF. Immunosuppressants: tools to investigate the physiological role of cytokines. BioEssays 1993 15 : 731. (Pubitemid 2010127)
25. Kang HG, Zhang D, Degauque N, Mariat C, Alexopoulos S, Zheng XX. Effects of cyclosporine on transplant tolerance: the role of IL-2. Am J Transplant 2007 7 : 1907. (Pubitemid 47037991)
26. Guerra G, Srinivas TR, Meier-Kriesche HU. Calcineurin inhibitor-free immunosuppression in kidney transplantation. Transpl Int 2007 20 : 813. (Pubitemid 47390195)
27. Guba M, Koehl GE, Neppl E, et al. Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer. Transpl Int 2005 18 : 89. (Pubitemid 41742951)
28. Dean PG, Lund WJ, Larson TS, et al. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 2004 77 : 1555. (Pubitemid 38703037)
29. Kuppahally S, Al-Khaldi A, Weisshaar D, et al. Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. Am J Transplant 2006 6 : 986. (Pubitemid 44356648)
30. Dubay DA, Wang X, Kuhn MA, Robson MC, Franz MG. The prevention of incisional hernia formation using a delayed-release polymer of basic fibroblast growth factor. Ann Surg 2004 240 : 179. (Pubitemid 38808250)
31. Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 2007 10 : 149. (Pubitemid 47305203)
32. Wood SC, Bushar G, Tesfamariam B. Inhibition of mammalian target of rapamycin modulates expression of adhesion molecules in endothelial cells. Toxicol Lett 2006 165 : 242. (Pubitemid 44026485)
33. Shegogue D, Trojanowska M. Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway. J Biol Chem 2004 279 : 23166. (Pubitemid 38685622)
34. Ong CT, Khoo YT, Mukhopadhyay A, et al. mTOR as a potential therapeutic target for treatment of keloids and excessive scars. Exp Dermatol 2007 16 : 394. (Pubitemid 46585367)
35. Abizaid A. Sirolimus-eluting coronary stents: a review. Vasc Health Risk Manag 2007 3 : 191. (Pubitemid 46860708)
36. Schäffer MR, Tantry U, van Wesep RA, Barbul A. Nitric oxide metabolism in wounds. J Surg Res 1997 71 : 25. (Pubitemid 27344032)
37. Yamasaki K, Edington HD, McClosky C, et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest 1998 101 : 967. (Pubitemid 28125274)